Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-11-28
1999-10-12
Ketter, James
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 691, 4353201, 435367, 435379, 435370, 435456, 530350, 536 234, 536 2372, A01N 4304
Patent
active
059655410
ABSTRACT:
The present invention provides a chimeric adenovirus coat protein, which differs from the wild-type coat protein by the introduction of a nonnative amino acid sequence. Such a chimeric adenovirus coat protein according to the invention is able to direct entry into cells of a vector comprising the coat protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus coat protein rather than the chimeric adenovirus coat protein. The chimeric coat protein preferably is a fiber, hexon, or penton protein. The present invention also provides an adenoviral vector that comprises the chimeric adenovirus coat protein, as well as methods of constructing and using such a vector.
REFERENCES:
patent: 4593002 (1986-06-01), Dulbecco
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5543328 (1996-08-01), McClelland et al.
patent: 5547932 (1996-08-01), Curiel et al.
patent: 5559099 (1996-09-01), Wickham et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5661133 (1997-08-01), Leiden et al.
patent: 5672344 (1997-09-01), Kelley et al.
patent: 5674722 (1997-10-01), Mulligan et al.
Falck-Pedersen, Abstract of National Institutes of Health Grant Application No. 1 P01 HL51746-01UB: 0004 entitled "Gene Therapy For Cystic Fibrosis" (1994).
Barinaga, M. Science, vol. 226, p. 1326, 1994.
Marshall, E. Science, vol. 269, pp. 1050-1055, 1995.
Crystal, R. Science, vol. 270, pp. 404-410, 1995.
Jolly, D. Cancer Gene Therapy, vol. 1(1), pp. 51-64, 1994.
Orkin et al. Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, 1995.
Hong et al., Virology, 185, 758-767 (1991).
Karyan et al., Virology, 202, 782-785 (1994).
Database WPI, Week 9316, Derwent Publications Ltd., AN 93-134470/16 (WO 93/07283 English abstract).
Database WPI, Week 9440, Derwent Publications Ltd., AN 94-317775/40 (WO 94/24299 English abstract).
Batra et al., Gene Therapy, 1, 255-260 (1994).
Boursnell et al., Gene, 13, 311-317 (1981).
Chu et al., Gene Therapy, 292-299 (1994).
Cotten et al., Proc. Natl. Acad. Sci., 87, 4033-4037 (1990).
Crystal, Science, 270, 404-410 (1995).
Han et al., Proc. Natl. Acad. Sci., 92, 9747-9751.
Horvath et al., J. Virol., 62, 341-345 (1988).
Huang et al., J. Virol., 69, 2257-2263 (1995).
Maraveyas et al., Acta Oncologica, 32, 741-746 (1993).
Mastrangeli et al., Ped. Pulm., Suppl. 12, 230, Ab. No. 180 (1995).
Mastrangeli et al., Human Gene Therapy, 7, 79-87 (1996).
Michael et al., The Journal of Biological Chemistry, 268, 6866-6869 (1993).
Michael et al., Gene Therapy, 660-668 (1995).
Miller et al., FASEB J., 9, 190-199 (1995).
Neda et al., J. Biol. Chem., 266, 14143-14146 (1991).
Russell et al., Nucleic Acids Research, 21, 1081-1085 (1993).
Silver et al., Virology, 165, 377-387 (1988).
Wickham et al., J. Cell. Biol., 127, 257-264 (1994).
Wickham et al., Gene Therapy, 2, 750-756 (1995).
Chroboczek et al., Virology, 186, 280-285 (1992).
Cotten et al., Proc. Natl. Acad. Sci., 89, 6094-6098 (1992).
Curiel et al., Proc. Natl. Acad. Sci., 88, 8850-8854 (1991).
Curiel et al., Human Gene Therapy, 3, 147-154 (1992).
Defer et al., Journal of Virology, 64(8), 3661-3673 (1990).
Dupuit et al., Human Gene Therapy, 6, 1185-1193 (1995).
Falgout et al., Journal of Virology, 62, 622-625 (1988).
Grubb et al., Nature, 371, 802-806 (1994).
Kass-Eisler et al., Proc. Natl. Acad. Sci., 90, 11498-11502 (1993).
Mathias et al., Journal of Virology, 68, 6811-6814 (1994).
Michael et al., Adenovirus Workshop, St. Andrews University, 52, 13-15 (1995).
Nemerow et al., In Biology of Vitronectins and Their Receptors, Preissner et al., eds., 177-184 (Elsevier Science Publishers).
Nemerow et al., Trends in Cell Biology, 4, 52-55 (1994).
Novelli et al., Virology, 185, 365-376 (1991).
Signas et al., Journal of Virology, 53(2), 672-678 (1985).
Wagner et al., Proc. Natl. Acad. Sci., 89, 6099-6103 (1992).
Watson et al., Journal of Virology, 69, 525-535 (1988).
Wickham et al., Cell, 73, 309-319 (1993).
Brough Douglas E.
Kovesdi Imre
Wickham Thomas J.
GenVec, Inc.
Ketter James
Yucel Irem
LandOfFree
Vectors and methods for gene transfer to cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vectors and methods for gene transfer to cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors and methods for gene transfer to cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652507